Belogent ointment, 30 g

Belogent ointment 30g

Name ENG

BELOGENT

Clinical and pharmacological group

Drug with antibacterial and anti-inflammatory action for external use

ATX code

Betamethasone in combination with antibiotics

Dosage

0.05% + 0.1% x 30g

Structure

1 g: betamethasone dipropionate 640 mcg, which corresponds to the content of betamethasone 500 mcg gentamicin (in the form of sulfate) 1 mg

Excipients: liquid paraffin, soft white paraffin.

Indications

Dermatoses, allergic and inflammatory skin diseases that respond to topical corticosteroid therapy, the course of which is complicated by a bacterial infection or there is a danger of its addition in children from 1 year of age and in adults:

eczema, diffuse neurodermatitis

dermatitis atopic, contact (including professional), allergic, seborrheic

Infected dermatitis resulting from insect bites

impetigo

psoriasis

lichen planus

phleboderma

anogenital itching.

INN / Active ingredient

betamethasone, gentamicin (sulfate form)

Contraindications

viral skin infections

lupus

perioral dermatitis

rosacea

skin reactions at the vaccination site

hypersensitivity to the components of Belogent.

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 4 years

Specifications

Category

Psoriasis

Scope of the drug

Dermatology

Release form

Ointment

Manufacturer country

Croatia

Package quantity, pcs

one

Scope of application

Dermatology

Minimum age from

1 year

Way of introduction

Outwardly

,

On the skin

Vacation conditions

Without recipe

Brand name

Belupo

The amount of the dosage form in the primary package

30 g

Primary packaging type

Tuba

Type of consumer packaging

Pack of cardboard

Anatomical and therapeutic characteristics

D07CC01 Betamethasone, in combination with antibiotics

Dosage form

Ointment for external use

Packaging

Box

The target audience

Children

Expiration date in days

1095

Package weight, g

45

Mode of application

:

The drug is intended for external use only.

A cream or ointment for external use is applied to the affected area with a thin layer in the amount necessary to cover the affected surface, 2 times / day, gently rubbing.

On areas with denser skin (for example, elbows, palms and feet), as well as places from which the drug is easily erased, Belogent can be applied more often.

The duration of a continuous course of treatment is usually no more than 4 weeks.

To prevent relapses in the treatment of chronic diseases, therapy should be continued for some time after the disappearance of all symptoms.

Repeated courses of therapy are possible during the year.

A cream for external use is used for the treatment of acute, incl.

weeping skin lesions.

Ointment for external use is intended for the treatment of subacute and chronic dermatoses, incl.

dry, lichenised and scaly lesions.

Pharmaco-therapeutic group

:

Topical glucocorticosteroid + antibiotic aminoglycoside

Dosage (volume) of the substance in the preparation

:

betamethasone dipropionate 640 mcg, which corresponds to the content of betamethasone 500 mcg, gentamicin (in the form of sulfate) 1 mg